Mical Paul
Sylhet Agricultural University(BD)Technion – Israel Institute of Technology(IL)Rambam Health Care Campus(IL)World Health Organization(CH)Infectious Diseases Institute(UG)Rappaport Family Institute for Research in the Medical Sciences(IL)McMaster University(CA)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance, Pneumonia and Respiratory Infections
Most-Cited Works
- → European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)(2021)914 cited
- → International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)(2019)880 cited
- → Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis(2010)715 cited
- → Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data(2014)644 cited
- → Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial(2018)602 cited